IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study

Background: Stem cell transplantation is emerging as a potential therapeutic strategy in several autoimmune diseases. However, the safety and feasibility of long-term combined intravenous (IV) and intrathecal (IT) administration of hUC-MSCs in relapse remitting multiple sclerosis (RRMS) and neuromye...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Lu, Zhengjuan, Zhu, Lin, Liu, Zhuo, Wu, Jiayong, Xu, Yun, Zhang, Cun-Jin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7506071/
https://ncbi.nlm.nih.gov/pubmed/33013641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados